Home / Resource Library / Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan

Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan

Study examined venetoclax for relapsed treatment of CLL in Japan.